Another incredible moment for PE-Storm at #VIVA25! Honored to have partnered with @PenumbraInc on this groundbreaking trial—paving the way for new standards in pulmonary embolism treatment and outcomes. Congratulations @RosovskyRachel @roblooksteinView quoted post on X
www.ahajournals.org Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation... BACKGROUND: Patients with intermediate-high risk pulmonary embolism (PE) have an elevated right ventricular (RV) to left ventricular (LV) diameter ratio and are at risk of early clinical decompensa... @RosovskyRachel Can you link to the publication?View quoted post on X
www.ahajournals.org Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation... BACKGROUND: Patients with intermediate-high risk pulmonary embolism (PE) have an elevated right ventricular (RV) to left ventricular (LV) diameter ratio and are at risk of early clinical decompensa... STORM-PE shows improved functional outcomes for mechanical thrombectomy at discharge and at 90 days @VIVAPhysicians #VIVA25View quoted post on X
www.ahajournals.org Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation... BACKGROUND: Patients with intermediate-high risk pulmonary embolism (PE) have an elevated right ventricular (RV) to left ventricular (LV) diameter ratio and are at risk of early clinical decompensa... Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Signific... prn.to/4qYWMObView quoted post on X
